
    
      Patients with a stable definite Rheumatoid Arthritis will be invited by their rheumatologists
      to participate at this study in 20 centers in France. After written informed consent will be
      obtained, the patients will be randomized in two arms:

        -  comorbidities

        -  auto-DAS The patients will be seen again in the same center six months later in order to
           collect the outcome measures.
    
  